Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Traws Pharma, Inc. (TRAW) had Return on Investments of 526.47% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.23M |
|
$-54.67M |
|
-- |
|
$0.23M |
|
$142.60M |
|
$-142.37M |
|
$-24.15M |
|
$-166.52M |
|
$-166.52M |
|
$-166.52M |
|
$-166.52M |
|
$-166.52M |
|
$-166.52M |
|
$-142.37M |
|
$-142.36M |
|
1.55M |
|
1.55M |
|
$-35.21 |
|
$-35.21 |
|
| Balance Sheet Financials | |
$24.95M |
|
$0.01M |
|
$0.01M |
|
$24.96M |
|
$11.53M |
|
-- |
|
$45.06M |
|
$56.59M |
|
$-31.63M |
|
$-31.63M |
|
$-31.63M |
|
3.65M |
|
| Cash Flow Statement Financials | |
$-29.79M |
|
$-3.65M |
|
$33.98M |
|
$20.82M |
|
$21.34M |
|
$0.52M |
|
$1.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-62997.35% |
|
-62997.35% |
|
-62992.04% |
|
-73682.74% |
|
-24192.04% |
|
$-29.79M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.13 |
|
2850.55 |
|
526.47% |
|
526.47% |
|
-667.11% |
|
|
Return on Investments |
526.47% |
$-8.66 |
|
$-19.19 |
|
$-19.19 |
|